Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

June 4 NEJM/going out on a limb

Tomorrow's edition has several of the big hit papers to come out of ASCO.

You heard it here first, crazy prediction - next year's post ASCO NEJM will include an article by Shapiro about Kevetrin (and here is the IF)IF they prove efficacy.

Most of the articles are abut trials farther along- the melanoma paper, prime example.

But so much has been written about p53 and the struggle to figure out a way to use it as a target: may make it in even if early data.

Wouldn't it be nice.

(Hey : what's up with that DLT?)